Puma Biotechnology Inc
NASDAQ: PBYI
$2.65
+$0.13 (+5.2%)
Closing Price on October 4, 2024
PBYI Articles
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this year.
Published:
Finviz.comWith the end of the year two weeks away, 10 stocks have already had gains of more than 400%. Investors in these stocks have been, if they held them for the year, wildly successful. 1....
Published:
ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their...
Published:
Last Updated: